Absci Corporation (ABSI)
NASDAQ · Healthcare
$8.16-1.63%
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- $1.8B
- P/E ratio
- —
- EPS
- —
- Volume
- 3,035,985
- 52-week high
- —
- 52-week low
- —
- Open
- $8.17
- Day high
- $8.53
- Day low
- $8.06
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | — | -$115.18M | -$0.84 |
| 2024 | $4.53M | -$103.11M | -$0.94 |
| 2023 | $5.72M | -$110.57M | -$1.20 |
| 2022 | $5.75M | -$104.9M | -$1.15 |
| 2021 | $4.78M | -$100.96M | -$2.08 |
About Absci Corporation
Absci Corporation operates as a biopharmaceutical company primarily focused on discovering novel drug targets and developing new therapeutic compounds. Leveraging its distinctive integrated drug creation platform, the firm generates potential biologic medicines and essential cell lines for manufacturing, which it provides to its collaborators, predominantly within the United States. This advanced platform is instrumental in facilitating the development of biologics by meticulously integrating the traditionally separate stages of drug discovery and cell line engineering into one streamlined process. Absci Corporation was founded in 2011 and is based in Vancouver, Washington.
- CEO
- Sean McClain
- Employees
- 156
- Country
- US
- IPO date
- Jul 22, 2021
Similar stocks
Other Healthcare companies
Frequently asked questions
- What is Absci Corporation's stock price today?
- ABSI is trading at $8.16 as of Jul 20, 2026.
- What is Absci Corporation's market cap?
- Absci Corporation (ABSI) has a market capitalization of $1.8B.
- Does Absci Corporation pay a dividend?
- Absci Corporation did not pay a dividend in its most recent reported fiscal year.
- What sector is Absci Corporation in?
- Absci Corporation operates in the Healthcare sector.